James E. P. Davidson
Vernalis (R&D) Limited (United Kingdom) · 41 works · 2,595 citations · h-index 17
Top works
- The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
- Structure−Activity Relationships for Cytotoxic Ruthenium(II) Arene Complexes Containing N,N-, N,O-, and O,O-Chelating Ligands
- A new class of single-molecule magnet: [Mn9O7(OAc)11(thme)(py)3(H2O)2] with an S = 17/2 ground state
- Kinetics of Aquation and Anation of Ruthenium( II ) Arene Anticancer Complexes, Acidity and X‐ray Structures of Aqua Adducts
- Indoline derivatives as 5-HT 2C receptor agonists
- S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth
- Magnetization tunneling in an enneanuclear manganese cage
- Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity
- Use of a Modified Leimgruber–Batcho Reaction to Prepare 6‐Chloro‐5‐fluoroindole
- Synthesis of medium-ring lactones via tandem methylenation/Claisen rearrangement of cyclic carbonates
- Synthesis of medium-ring lactones via tandem methylenation/Claisen rearrangement of cyclic carbonates
- Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor
- Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1
- Identification of 4-methyl-1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles as 5-HT2C receptor agonists
- Exploiting supramolecular chemistry in metal recovery: novel zwitterionic extractants for nickel( ii ) salts
- Molecular dynamics simulations to aid the rational design of organic friction modifiers
- Cation and anion selectivity of zwitterionic salicylaldoxime metal salt extractants
- Transport of metal salts by zwitterionic ligands; simple but highly efficient salicylaldoxime extractants
- Fragment Merging Using a Graph Database Samples Different Catalogue Space than Similarity Search
- Abstract 4482: S64315 (MIK665) is a potent and selective Mcl1 inhibitor with strong antitumor activity across a diverse range of hematologic tumor models